Compare Aurobindo Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA CIPLA AUROBINDO PHARMA/
CIPLA
 
P/E (TTM) x 9.9 31.7 31.1% View Chart
P/BV x 3.2 4.2 76.0% View Chart
Dividend Yield % 0.3 0.5 62.4%  

Financials

 AUROBINDO PHARMA   CIPLA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-20
CIPLA
Mar-21
AUROBINDO PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs838879 95.4%   
Low Rs281411 68.5%   
Sales per share (Unadj.) Rs394.2237.6 165.9%  
Earnings per share (Unadj.) Rs48.529.8 163.1%  
Cash flow per share (Unadj.) Rs65.042.2 154.1%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %0.50.8 69.1%  
Book value per share (Unadj.) Rs286.9226.7 126.5%  
Shares outstanding (eoy) m585.93806.46 72.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.42.7 52.3%   
Avg P/E ratio x11.521.6 53.2%  
P/CF ratio (eoy) x8.615.3 56.3%  
Price / Book Value ratio x2.02.8 68.6%  
Dividend payout %6.216.8 36.8%   
Avg Mkt Cap Rs m327,872519,826 63.1%   
No. of employees `000NANA-   
Total wages/salary Rs m32,19232,518 99.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m230,985191,596 120.6%  
Other income Rs m1,9192,698 71.1%   
Total revenues Rs m232,904194,294 119.9%   
Gross profit Rs m48,38241,841 115.6%  
Depreciation Rs m9,66710,031 96.4%   
Interest Rs m3,0511,607 189.9%   
Profit before tax Rs m37,58232,901 114.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,1358,888 102.8%   
Profit after tax Rs m28,44724,013 118.5%  
Gross profit margin %20.921.8 95.9%  
Effective tax rate %24.327.0 90.0%   
Net profit margin %12.312.5 98.3%  
BALANCE SHEET DATA
Current assets Rs m164,125132,095 124.2%   
Current liabilities Rs m113,86845,916 248.0%   
Net working cap to sales %21.845.0 48.4%  
Current ratio x1.42.9 50.1%  
Inventory Days Days1568 22.6%  
Debtors Days Days687 1,038.8%  
Net fixed assets Rs m123,507116,277 106.2%   
Share capital Rs m5861,613 36.3%   
"Free" reserves Rs m167,518181,232 92.4%   
Net worth Rs m168,104182,844 91.9%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m287,632248,372 115.8%  
Interest coverage x13.321.5 62.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.8 104.1%   
Return on assets %11.010.3 106.2%  
Return on equity %16.913.1 128.9%  
Return on capital %24.217.7 136.5%  
Exports to sales %46.431.3 148.2%   
Imports to sales %15.110.9 138.4%   
Exports (fob) Rs m107,12659,951 178.7%   
Imports (cif) Rs m34,90220,911 166.9%   
Fx inflow Rs m107,44568,051 157.9%   
Fx outflow Rs m38,99120,911 186.5%   
Net fx Rs m68,45447,140 145.2%   
CASH FLOW
From Operations Rs m43,81337,552 116.7%  
From Investments Rs m-15,676-23,872 65.7%  
From Financial Activity Rs m-19,472-13,299 146.4%  
Net Cashflow Rs m8,712509 1,711.3%  

Share Holding

Indian Promoters % 48.8 15.0 325.1%  
Foreign collaborators % 3.1 21.7 14.1%  
Indian inst/Mut Fund % 38.4 41.1 93.4%  
FIIs % 23.7 24.8 95.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 63.3 76.1%  
Shareholders   243,315 408,401 59.6%  
Pledged promoter(s) holding % 22.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   ZENOTECH LABS  DR. REDDYS LAB  LASA SUPERGENERICS  UNICHEM LAB  PARENT.DRUGS  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 5, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS